This AOP is licensed under a Creative Commons Attribution 4.0 International License.
Aryl hydrocarbon receptor activation leading to early life stage mortality via impeded craniofacial development
Point of Contact
- Prarthana Shankar
|Author status||OECD status||OECD project||SAAOP status|
|Under development: Not open for comment. Do not cite|
This AOP was last modified on October 21, 2022 15:53
Revision dates for related pages
|Activation, AhR||December 20, 2022 08:29|
|dimerization, AHR/ARNT||September 16, 2017 10:14|
|Decrease, sox9 expression||August 11, 2022 15:09|
|Increase, Early Life Stage Mortality||March 22, 2018 10:23|
|Facial cartilage structures are reduced in size and morphologically distorted||December 20, 2018 04:16|
|Increase, slincR expression||August 01, 2022 13:37|
|Activation, AhR leads to dimerization, AHR/ARNT||March 22, 2018 11:02|
|dimerization, AHR/ARNT leads to Increase, slincR expression||September 08, 2022 18:44|
|Activation, AhR leads to Decrease, sox9 expression||October 20, 2022 16:41|
|Increase, slincR expression leads to Decrease, sox9 expression||September 08, 2022 18:45|
|Decrease, sox9 expression leads to Smaller and morphologically distorted facial cartilage structures||October 20, 2022 16:46|
|Smaller and morphologically distorted facial cartilage structures leads to Increase, Early Life Stage Mortality||October 21, 2022 15:56|
|Increase, slincR expression leads to Smaller and morphologically distorted facial cartilage structures||September 08, 2022 18:46|
|Activation, AhR leads to Increase, Early Life Stage Mortality||April 14, 2019 15:17|
|Activation, AhR leads to Smaller and morphologically distorted facial cartilage structures||October 21, 2022 14:45|
|2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)||February 09, 2017 14:32|
The Aryl Hydrocarbon Receptor (Ahrs) are evolutionarily conserved ligand-dependent transcription factors that can be activated by structurally diverse compounds such as halogenated aromatic hydrocarbons, polycyclic aromatic hydrocarbons, and polychlorinated biphenyls. Ahr activation can cause developmental toxicity, including craniofacial malformations, that can lead to early-stage mortality. The current AOP describes a novel adverse outcome pathway (AOP) which describe how Ahr activation (molecular initiating event; MIE) can lead to early-stage mortality (adverse outcome; AO), via craniofacial malformations. The AOP includes two novel key events (KEs), increase in slincR expression, a newly characterized long non-coding RNA that has regulatory functions, and decrease in SOX9 gene and protein expression, a critical transcription factor implicated in several processes including chondrogenesis. Using a key event relationship (KER)-by-KER approach, we collected evidence using both relevant zebrafish literature as well as through broader key word searches in the AbstractSifter tool. Weight of evidence for each KER was assessed to inform overall assessment of the two AOPs which is presented here. Overall confidence levels ranged between medium and strong, with few inconsistencies as well several opportunities for future research identified. While the AOP has only been demonstrated in zebrafish with TCDD as an Ahr activator, we provide lines of evidence for the AOP to apply to majority of animals, as well as many Ahr activating chemicals. The addition of the AOP into the AOP-Wiki helps expand the growing Ahr-related AOP network.
AOP Development Strategy
<<<The key events (KEs) associated with AOPs 455 and 456 are predominantly similar, with the exception of KE4 in each AOP. KE4 in AOP 455 is Event 1559: “Facial cartilage structures are reduced in size and morphologically distorted”, and KE4 in AOP 456 is Event 317: “Altered, Cardiovascular development/function.” While AOP 456 may be of higher biologically relevance, both AOPs are ecologically important and contribute significantly to the growing network of AOPs beginning with the activation of the Aryl hydrocarbon receptor (Ahr). Since both AOPs have several overlapping KEs, some redundant text is to be expected in the individual AOP-Wiki pages.>>>
The Aryl Hydrocarbon Receptor (Ahrs) are evolutionarily conserved ligand-dependent transcription factors that can be activated by a wide range of structurally diverse compounds (Denison and Nagy 2003; Hahn et al. 2017).
Ahr activation by environmental pollutants including halogenated aromatic hydrocarbons (HAHs), polycyclic aromatic hydrocarbons (PAHs), and polychlorinated biphenyls (PCBs) can lead to a variety of adverse health effects, such as dysfunction to the immune, reproductive, and cardiovascular systems (Hansen et al. 2014; Hernandez-Ochoa et al. 2009; Stevens et al. 2009; Zhang 2011), as well as improper development and neurobehavior (Garcia et al. 2018). Ahr activation is also associated with tumor promotion and carcinogenesis (Safe et al. 2013).
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a bioaccumulative and highly toxic HAH, is typically used as the prototypical molecular probe to investigate Ahr-related outcomes and is thus one of the most thoroughly investigated of the known Ahr agonists. Several studies in model organisms such as zebrafish and rodents have shown that Ahr-deficient animals in gene knock-out studies have either diminished or completely nonexistent harmful effects of both TCDD and several PAHs (Fernandez-Salguero et al. 1996; Garcia et al. 2018; Goodale et al. 2015; Harrill et al. 2016), highlighting the significance of the Ahrs in mediating toxicological outcomes of the Ahr-active chemicals.
Canonical Ahr signaling involves the conversion of the inactive Ahr, which is present in the cytoplasm, to its active form that can translocate to the nucleus and dimerize with the Ahr nuclear translocator (ARNT) (Wright et al. 2017). The Ahr-ARNT heterodimer can consequently regulate transcription of downstream genes either indirectly, or directly, which is the case for the cytochrome P450s (CYPs) that are induced via the direct binding of the heterodimer to the aryl hydrocarbon response elements (Ahres) (Lo and Matthews 2012).
Upon exposure to various Ahr activating chemicals, craniofacial malformations and cardiovascular toxicity have been identified under various exposure paradigms (Antkiewicz et al. 2005; Henry et al. 1997; Li et al. 2014). Importantly, developing zebrafish exposed to TCDD have severe heart and vasculature malformations, in addition to jaw structure impairments that occur secondarily to inhibited chondrogenesis (Carney et al. 2006). One of the genes whose expression is most reduced in the jaw upon TCDD exposure in zebrafish is sox9b, sry-box containing gene 9b (Xiong et al. 2008). This gene, one of two zebrafish paralogs of the SOX9 gene, is a critical transcription factor that has been implicated in several processes including chondrogenesis and cardiac development, in addition to skeletal development, male gonad genesis, and cancer progression (Lefebvre and Dvir-Ginzberg 2017; Panda et al. 2021). Based on current knowledge, primarily from developmental zebrafish studies, it is apparent that there are strong relationships between Ahr, SOX9, and craniofacial (AOP 455) or cardiovascular (AOP 456) malformations that can be causally linked in an AOP network. Evidence from studies conducted with other taxa provide further support and aid in evaluation of the domain of applicability as well as the breadth of the stressors that can cause the different relationships described in the two AOPs.
A KER-by-KER approach was leveraged to gather different lines of evidence to support the two proposed AOPs, with a focus on adjacent relationships, and including non-adjacent KERs where applicable. Both supporting and contradicting evidence was collected for the KERs and classified as evidence for essentiality of the upstream KE to occur for the downstream KE to happen for each KER, biological plausibility of each KER, or empirical evidence supporting or negating each KER. The tools and sources utilized to assemble literature were dependent on the extent of information already included in the AOP-Wiki. Of the seven adjacent KERs between the two AOPs, two have already been well-described and reviewed in the AOP-Wiki and will not be discussed in this report. These relationships are KER1 (Relationship 972: Activation, AhR leads to dimerization, AHR/ARNT) and KER5 of AOP 456 (Relationship 1567: Altered, Cardiovascular development/function leads to Increase, Early Life Stage Mortality). Additionally, evidence supporting the non-adjacent KER, Activation, AhR leads to Increase, Early Life Stage Mortality (Relationship 984) has also already been included in the AOP-Wiki, and provides strong support for the relationship between the molecular initiating event and the adverse outcome for both proposed AOPs.
Between the two proposed AOPs, we discuss a total of four KERs that include “Increase, slincR expression” as either the upstream or the downstream key event: KER2 (Relationship 2683: dimerization, AHR/ARNT leads to Increase, slincR expression) and KER3 (Relationship 2684: Increase, slincR expression leads to Decrease, sox9 expression), as well as the non-adjacent KERs, Relationship 2690: Increase, slincR expression leads to Smaller and morphologically distorted facial cartilage structures (AOP 455), and Relationship 2727: Increase, slincR expression leads to Altered, Cardiovascular development/function (AOP 456). Present literature on slincR is relatively limited, therefore evidence pertaining to these four KERs was gathered primarily from two zebrafish studies that discovered and characterized slincR (Garcia et al. 2017; Garcia et al. 2018b). Additional supporting evidence for the regulatory role of lncRNAs and the complexity of the molecular signaling pathways leading up to the malformations, was obtained from the reference lists from the two Garcia studies, and other relevant literature associated with lncRNAs.
Of the three remaining adjacent KERs, moderate biological plausibility evidence for Relationship 2686: Smaller and morphologically distorted facial cartilage structures leads to Increase, Early Life Stage Mortality (AOP 455) was identified. Evidence for the two relationships that include “Decrease, sox9 expression” as a key event, Relationship 2685: Decrease, sox9 expression leads to Smaller and morphologically distorted facial cartilage structures (AOP 455) and Relationship 2691: Decrease, sox9 expression leads to Altered, Cardiovascular development/function (AOP 456) were gathered using a systematic literature search. Evidence collection for the non-adjacent KERs, Relationship 2688: Activation, AhR leads to Decrease, sox9 expression, Relationship 2689: Activation, AhR leads to Smaller and morphologically distorted facial cartilage structures, and Relationship 2765: Activation, AhR leads to Altered, Cardiovascular development/function were all addressed in a similar manner.
We used Abstract Sifter (version 7) (Baker et al. 2017) to systematically collect evidence for three non-adjacent KERS, and the two adjacent KERs pertaining to SOX9 repression. The Microsoft Excel-based application enhances the existing functions of PubMed searches. Search terms for each of the KERs were used to identify a list of potentially relevant sources. Results were filtered via manual review based on the information in the titles and abstracts, such as relevant in vitro platforms, life-stage and toxicity endpoints measured, and the scientific context of the search results compared to that of the two AOPs. Non-relevant studies were excluded from further analysis. Our literature search methodology included two main drawbacks: 1. While our broad search terms captured several potentially relevant articles, there was a possibility of missing out on studies that did not, for example, include “AHR” or “aryl” in their abstracts, but were investigating one or more of the relevant KEs in this report using a known Ahr activator as the chemical. 2. Our search results were restricted to literature within PubMed, and thus did not capture studies outside of this database unless we happened to include them from reference lists of the selected manuscripts. Once literature from the search results was filtered, a concordance table was built for each of the KERs 2685, 2691, 2688, 2689, and 2765 evaluating and classifying the experiments in the results based on the type of evidence they provide. The concordance tables can be found in the respective KER pages. Occasionally, additional references that were not present in the initial results’ lists were included from the references cited in studies identified via the original search. Of note, information present in the concordance tables is by no means comprehensive, and instead, is a summary of the relevant results obtained from our AbstractSifter searches and filters.
Summary of the AOP
Molecular Initiating Events (MIE)
Key Events (KE)
Adverse Outcomes (AO)
|Type||Event ID||Title||Short name|
|MIE||18||Activation, AhR||Activation, AhR|
|KE||944||dimerization, AHR/ARNT||dimerization, AHR/ARNT|
|KE||2021||Increase, slincR expression||Increase, slincR expression|
|KE||2020||Decrease, sox9 expression||Decrease, sox9 expression|
|KE||1559||Facial cartilage structures are reduced in size and morphologically distorted||Smaller and morphologically distorted facial cartilage structures|
|AO||947||Increase, Early Life Stage Mortality||Increase, Early Life Stage Mortality|
Relationships Between Two Key Events (Including MIEs and AOs)
|Activation, AhR leads to dimerization, AHR/ARNT||adjacent||High||High|
|dimerization, AHR/ARNT leads to Increase, slincR expression||adjacent||High||High|
|Increase, slincR expression leads to Decrease, sox9 expression||adjacent||High||High|
|Decrease, sox9 expression leads to Smaller and morphologically distorted facial cartilage structures||adjacent||High||High|
|Smaller and morphologically distorted facial cartilage structures leads to Increase, Early Life Stage Mortality||adjacent||Moderate||Low|
|Activation, AhR leads to Decrease, sox9 expression||non-adjacent||High||High|
|Increase, slincR expression leads to Smaller and morphologically distorted facial cartilage structures||non-adjacent||High||High|
|Activation, AhR leads to Increase, Early Life Stage Mortality||non-adjacent||High||High|
|Activation, AhR leads to Smaller and morphologically distorted facial cartilage structures||non-adjacent||High|
Life Stage Applicability
Overall Assessment of the AOP
See details below.
Domain of Applicability
Life Stage and Sex
The relationships between Ahr, Arnt, slincR and sox9b, and cardiac and craniofacial malformations have been well established in developing zebrafish, specifically as embryos, and thus sex is not a relevant parameter.
Evidence gathered suggests that the domain of applicability covers most vertebrates, from fish to humans and other wildlife. It is important to highlight that while all the relationships within the AOP have been observed definitively in one species (Danio rerio), there is strong evidence for specific KERs in species other than zebrafish. For example, Ahr’s evolutionarily conserved role as a master regulator of toxicity of several environmental pollutants has been shown in animals including fish, birds, rodents, and humans (Hahn et al. 2017). Another example is SOX9’s highly conserved role as a critical transcriptional factor in craniofacial and cardiac development in animals such as fish, rodents, and amphibians (Garside et al. 2015; Lee and Saint-Jeannet 2011). Additionally, while slincR has only been described in zebrafish so far, it is worth noting that putative mammalian orthologs have been identified (Garcia et al. 2018b), increasing the possibility that the zebrafish-specific results can be translated to other organisms. The formation of craniofacial structures is a predominantly evolutionarily conserved dynamic and complex process that begins early in embryonic development (Helms et al. 2005; Kuratani 2005). Consequently, craniofacial development can be thought of as a potential target of disruption in early embryos, and an AOP network around this key event would be highly relevant to both humans and general wildlife. Thus, the different lines of evidence suggest that the taxonomic domain of applicability for the two proposed AOPs can likely cover most vertebrates.
Essentiality of the Key Events
Direct evidence for the essentiality of several of the key events in the AOP has been provided by gene modification and knockout studies of the Ahr, slincR, and sox9b (one of two orthologs of SOX9) genes primarily in zebrafish. Highlights of the most important studies are provided here:
Canonical Ahr signaling involves the conversion of the inactive Ahr, which is present in the cytoplasm, to its active form that can translocate to the nucleus and dimerize with the Ahr nuclear translocator (ARNT) (Wright et al. 2017). Evidence suggests that the Ahr/ARNT heterodimer can consequently regulate gene expression within the Ahr signaling cascade.
Increase, slincR expression
Decrease, sox9 expression
Facial cartilage structures are reduced in size and morphologically distorted
While we are unaware of studies investigating the essentiality of normal facial structure for survival, it is conceivable to conclude that affected animals could have reduced feeding, which can decrease their chance of survival (Noble et al. 2012; Olsvik et al. 2021).
Increase, Early Life Stage Mortality
This is the terminal key event in the AOP and hence its essentiality for downstream events cannot be evaluated.
- Ahr – strong : Strongest Biological Plausibility evidence for AOPs 455 and 456 comes from our extensive understanding of the Ahr signaling pathway in multiple different organisms. The functional roles of Ahr and its binding partners, including ARNT, have been well-studied (Fujii-Kuriyama and Kawajiri 2010), and it is well known that the Ahr signaling pathway mediates a variety of physiological and toxicological functions (Larigot et al. 2018).
- slincR and sox9 – strong: Strong evidence for the Biological Plausibility of slincR having a role in AOPs 455 and 456 comes from the nature of lncRNAs which is such that they have diverse functions and can regulate gene expression at multiple levels, including by interacting with DNA, RNA, proteins, and altering transcription of both neighboring and distant genes (Statello et al. 2021). Additionally, slincR (in situ hybridization) and sox9b (immunohistochemistry for sox9b-eGFP) are expressed in adjacent and overlapping tissues through multiple stages of zebrafish development, such as in the eye, otic vesicle, and in the lower jaw (Garcia et al. 2017) providing one line of evidence for slincR being able to regulate sox9b gene expression. Further, a capture hybridization analysis of RNA targets (CHART) experiment in both DMSO- and TCDD-exposed 48 hpf zebrafish identified enrichment of slincR in the 5’UTR of the sox9b locus (Garcia et al. 2018b) pointing to possible interaction between slincR and sox9b.
- slincR and craniofacial development - strong: Across multiple stages of zebrafish development, slincR is expressed in the jaw/snout region, as well as in the eye and otic vesicle (Garcia et al. 2017). In addition, upon exposure to TCDD (a strong Ahr activating chemical), slincR expression increases in both the otic vesicle, as well as the lower jaw/snout region (Garcia et al. 2017). Knockdown of slincR expression in developing zebrafish also alters expression of sox9b, as well as certain downstream targets of sox9, such as notch3, adamts3, fabp2, sfrp2, and fgfr3 (Garcia et al. 2017). These are different lines of Biological Plausibility evidence for slincR being a mediator between Ahr activation and craniofacial/cartilage malformations.
- Sox9 and craniofacial development - strong: Strongest Biological Plausibility evidence comes from studies in multiple species showing the spatiotemporal expression of sox9 in the developing cartilage structures of the jaw suggesting possible role of sox9 in both craniofacial development and dysfunction. For example, in mice, sox9 mRNA is widely expressed in the condylar anlage and Meckel’s cartilage (Shibata et al. 2006), and the sox9 protein in the tissue layer of secondary cartilage (Hirouchi et al. 2018; Zhang et al. 2013). Additionally, sox9 is expressed widely during palatogenesis (Nie 2006; Watanabe et al. 2016) and is also found in the temporomandibular joint of developing mice (TMJ) (Wang et al. 2011). There is some evidence for sox9 being expressed in the condyle cartilage, as well as the proliferative layer and in the chondrocytes of developing rats (Al-Dujaili et al. 2018; Rabie and Hägg 2002). Similarly, sox9 expression has been found in developing cartilage structures of rabbits, duck, quail, zebrafish and salmon, and opposum to name a few animals, increasing the strength of the biological plausibility of sox9 being involved in craniofacial development and consequently, the signaling mechanisms preceding craniofacial malformations.
- Craniofacial malformations and early-stage mortality - moderate: It is reasonable to infer that malformed jaw structure of animals in the wild could impact their feeding success, leading to reduced growth and possible early mortality. However, few studies have demonstrated the relationships between jaw malformations, reduced feeding, and mortality, especially in fish (Noble et al. 2012).
- Ahr activation leading to early life stage mortality has been well-studied. The KER page (https://aopwiki.org/relationships/984) has examples in difference species for empirical evidence for this relationship.
- Strongest evidence for dose concordance between Ahr activation, slincR induction, and sox9 repression comes from a developing zebrafish study that utilized TCDD as the Ahr activating chemical. The concentration-response experiment showed that cyp1a (biomarker for Ahr activation) and slincR expression increased in parallel as TCDD exposure concentration increased, and that cyp1a and slincR are induced at TCDD exposure concentrations lower than concentrations at which sox9b is repressed (Garcia et al. 2018b).
- Both cyp1a and slincR were significantly induced starting at 0.0625 ng/mL TCDD exposure.
- Significant cyp1a (~log2FC = 6) and slincR (~log2FC = 2) inductions were detected at 0.0625 ng/mL TCDD, while significant sox9b repression (~log2FC = -1) was detected only at 0.5ng/mL TCDD.
- (Garcia et al. 2018b) also showed that with increasing concentrations of TCDD, the severity of overall developmental malformations, including pericardial edema (indicator of potential cardiotoxicity) and jaw malformations increased.
- Strong dose concordance has been determined between cardiovascular malformations and early life stage mortality (please see KER page: https://aopwiki.org/relationships/1567), however, to the best of out knowledge, no systematic effort has been performed to identify “dose concordance” evidence for the KER between craniofacial malformations and early life stage mortality.
Uncertainties, inconsistencies, data gaps
While we have listed out various possible uncertainties, inconsistencies, and data gaps in the respective KER pages, here we highlight the most important ones:
- One possible inconsistency in the literature is that not all ARNT isoforms in a particular species (for example, zebrafish) are important for mediating in vivo toxicity (Prasch et al. 2004), and future research could help clarify the relative influence of the different Ahr binding partners. The most well-studied Ahr binding partner is ARNT and it does appear to be important for TCDD toxicity – hence it is included as a KE in AOPs 455 and 456.
- While the relationships in AOPs 455 and 456 have been definitively shown with TCDD as the activating chemical, future research must investigate the KERs with other Ahr activators, such as PAHs and other HAHs. Similarly, future research in organisms other than zebrafish, will add significantly to the weight of evidence for AOPs 455 and 456.
- One inconsistency comes from a study exposing 16 individual PAHs to developing zebrafish where none were associated with a significant decrease in sox9b expression, despite six inducing both cyp1a and slincR expression (Garcia et al. 2018b). It is possible that the PAHs that are rapidly metabolized (unlike TCDD) induce different gene expression changes upon Ahr activation, or that the slincR/sox9b gene expression alterations are tissue-specific and are thus unable to be resolved consistently in whole animal transcriptomic studies.
- Morpholino knockdown of sox9b in zebrafish led to a significant increase in slincR expression suggesting that slincR and sox9b may share overlapping regulatory networks that is not fully understood (Garcia et al., 2018).
- We note that slincR is not the only mechanism of regulation of sox9. Other studies have found evidence for different regulatory mechanisms of sox9, but the circumstances under which different pathways are turned on is still unknown (Dash et al., 2021; Fu et al., 2018).
- Impact of absence of slincR has only been studied with morpholino knockdown experiments (Garcia et al., 2017; Garcia et al., 2018), which have two relevant drawbacks: 1. Inability to maintain slincR repression by 72 hpf since morpholinos are transient in nature, and 2. Incomplete functional knockout which prevents us from understanding the true impact of the absence of slincR. Future studies using CRISPR-Cas-generated knockout lines, for example, will help overcome both limitations.
- Few studies have showed an opposite relationship between sox9 expression and the size of cartilage structures.
- Conditional knockout of setdb1 (histone methyltransferase) specifically in the murine Meckel’s cartilage led to and enlargement of the cartilage structure as well as the proliferation of chondrocytes, however, sox9 expression was significantly repressed (Yahiro et al., 2017).
- Experimental unilateral anterior crossbite created in rats led to decreased ratio of the hypertrophic cartilage layer in the experiment group, which was evidence for obvious cartilage degradation. This was accompanied by induction of sox9 expression (Zhang et al., 2013b).
- One recent zebrafish study using the CRISPR-Cas9 tool, demonstrated that sox9a but not sox9b was required for normal cartilage development (Lin et al., 2021). This is inconsistent with all previous research showing the importance of both sox9a and sox9b for cartilage development in zebrafish.
Known Modulating Factors
|Modulating Factor (MF)||Influence or Outcome||KER(s) involved|
Strongest quantitative understanding for the AOPs 455 and 456 is between the MIE (Activation, Ahr) and the AO (Increase, Early Life Stage Mortality) and is described in detail in the KER page (Event 984; https://aopwiki.org/relationships/984). Additionally, for the halogenated aromatic hydrocarbons (HAHs), we have a strong quantitative understanding of the binding affinity of the different chemicals to the Ahr which partially led to the widespread use of the toxic equivalency factor (TEF) concept for humans, fish, and other wildlife risk assessment (Van den Berg et al. 1998). On the other hand, models that currently exist for chemicals such as the polycyclic aromatic hydrocarbons (PAHs) are often considered oversimplified due to the possible differences in receptor binding affinity and consequent differential metabolism and toxicity (Billiard et al. 2008).
The presence of two measurable gene expression events (SOX9 and slincR) as well as easily observable zebrafish toxicity phenotypes in AOPs 455 and 456 has given opportunity for the beginning of our quantitative understanding of the pathways. (Garcia et al. 2018b) conducted a TCDD concentration-response experiment in developing zebrafish and determined that by 0.125 ng/mL TCDD exposure for one hour at around 6 hpf, zebrafish had malformations in the developing jaw and pericardial edema, which was statistically significant at 0.25 ng/mL TCDD exposure. The study also measured cyp1a, slincR, and sox9b expression, and showed significant cyp1a (a measure of Ahr activation) and slincR induction from 0.0625 ng/mL, and a trend for sox9b repression from 0.125 ng/mL which was significant from 0.5 ng/mL TCDD exposure compared to the DMSO vehicle control. Additionally, slincR morpholino knockdown which reduced slincR expression by 98% in control animals, and by 81% in TCDD-exposed zebrafish compared to their respective control morphants (Garcia et al. 2017) significantly altered sox9b spatial and quantitative expression (Garcia et al. 2017), as well as had impacts on both craniofacial development and the cardiovascular system of developing zebrafish (Garcia et al. 2018b). This preliminary quantitative understanding between several of the relationships in the two AOPs is not available for other chemicals, or taxonomic groups or species.
Considerations for Potential Applications of the AOP (optional)
With the diversity of ligands that bind and activate the Ahrs, and the variety of biological and toxicological functions these receptors are involved in, AOPs describing different aspects of the Ahr signaling pathway could provide immense potential for cross-chemical and cross-taxa extrapolations. Additionally, the AOP networks can help prioritize the most relevant mechanistic data for regulatory decision making, while also identifying critical knowledge gaps for future research. Several in vitro and in silico assays are being leveraged to identify chemical structures that activate the Ahr (Larsson et al. 2018), however, inclusion of toxicogenomics data in ecological risk assessment is the next major step that can help overcome some of the challenges that current ecotoxicologists face, while providing tools for a tiered hazard evaluation strategy. For example, a deeper understanding of the mechanisms of toxicity endpoints can not only help illuminate the specific conditions under which malformations might occur, but it can also provide phenotypic-specific genetic biomarkers, such as slincR and SOX9, that can be easily measured in order to conduct reliable risk assessment. This approach can also be used for accurately predicting contaminants and their biological targets, and if the biomarkers are conserved across species which is likely the case for slincR and SOX9, gene expression measurements could also be used for predicting toxicant responses across a broad diversity of phylogenetic groups. Overall, the two AOPs (AOP 455 and 456) have the potential to 1. Expand on the Ahr-related AOP network to gain a more comprehensive view of Ahr-related processes to support regulatory decisions, and 2. Integrate toxicogenomics into the risk assessment paradigm for Ahr activating pollutants to enable extrapolations across both chemicals and taxa, while also identifying key differences between them.
Al-Dujaili M, Milne TJ, Cannon RD, Farella M. 2018. Postnatal expression of chondrogenic and osteogenic regulatory factor mrna in the rat condylar cartilage. Arch Oral Biol. 93:126-132.
Antkiewicz DS, Burns CG, Carney SA, Peterson RE, Heideman W. 2005. Heart malformation is an early response to tcdd in embryonic zebrafish. Toxicological Sciences. 84(2):368-377.
Baker N, Knudsen T, Williams A. 2017. Abstract sifter: A comprehensive front-end system to pubmed. F1000Res. 6.
Billiard SM, Meyer JN, Wassenberg DM, Hodson PV, Di Giulio RT. 2008. Nonadditive effects of pahs on early vertebrate development: Mechanisms and implications for risk assessment. Toxicol Sci. 105(1):5-23.
Carney SA, Prasch AL, Heideman W, Peterson RE. 2006. Understanding dioxin developmental toxicity using the zebrafish model. Birth Defects Res A Clin Mol Teratol. 76(1):7-18.
Denison MS, Nagy SR. 2003. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol. 43:309-334.
Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. 1996. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol. 140(1):173-179.
Fujii-Kuriyama Y, Kawajiri K. 2010. Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc Jpn Acad Ser B Phys Biol Sci. 86(1):40-53.
Garcia GR, Bugel SM, Truong L, Spagnoli S, Tanguay RL. 2018a. Ahr2 required for normal behavioral responses and proper development of the skeletal and reproductive systems in zebrafish. PLoS One. 13(3):e0193484.
Garcia GR, Goodale BC, Wiley MW, La Du JK, Hendrix DA, Tanguay RL. 2017. In vivo characterization of an ahr-dependent long noncoding rna required for proper sox9b expression. Mol Pharmacol. 91(6):609-619.
Garcia GR, Shankar P, Dunham CL, Garcia A, La Du JK, Truong L, Tilton SC, Tanguay RL. 2018b. Signaling events downstream of ahr activation that contribute to toxic responses: The functional role of an ahr-dependent long noncoding rna (slincr) using the zebrafish model. Environ Health Perspect. 126(11):117002.
Garside VC, Cullum R, Alder O, Lu DY, Vander Werff R, Bilenky M, Zhao Y, Jones SJ, Marra MA, Underhill TM et al. 2015. Sox9 modulates the expression of key transcription factors required for heart valve development. Development. 142(24):4340-4350.
Goodale BC, La Du J, Tilton SC, Sullivan CM, Bisson WH, Waters KM, Tanguay RL. 2015. Ligand-specific transcriptional mechanisms underlie aryl hydrocarbon receptor-mediated developmental toxicity of oxygenated pahs. Toxicol Sci. 147(2):397-411.
Gordon CT, Attanasio C, Bhatia S, Benko S, Ansari M, Tan TY, Munnich A, Pennacchio LA, Abadie V, Temple IK et al. 2014. Identification of novel craniofacial regulatory domains located far upstream of sox9 and disrupted in pierre robin sequence. Hum Mutat. 35(8):1011-1020.
Hahn ME, Karchner SI, Merson RR. 2017. Diversity as opportunity: Insights from 600 million years of ahr evolution. Curr Opin Toxicol. 2:58-71.
Hansen DA, Esakky P, Drury A, Lamb L, Moley KH. 2014. The aryl hydrocarbon receptor is important for proper seminiferous tubule architecture and sperm development in mice. Biol Reprod. 90(1):8.
Harrill JA, Layko D, Nyska A, Hukkanen RR, Manno RA, Grassetti A, Lawson M, Martin G, Budinsky RA, Rowlands JC et al. 2016. Aryl hydrocarbon receptor knockout rats are insensitive to the pathological effects of repeated oral exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Appl Toxicol. 36(6):802-814.
Helms JA, Cordero D, Tapadia MD. 2005. New insights into craniofacial morphogenesis. Development. 132(5):851-861.
Henry TR, Spitsbergen JM, Hornung MW, Abnet CC, Peterson RE. 1997. Early life stage toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in zebrafish (danio rerio). Toxicol Appl Pharmacol. 142(1):56-68.
Hernandez-Ochoa I, Karman BN, Flaws JA. 2009. The role of the aryl hydrocarbon receptor in the female reproductive system. Biochem Pharmacol. 77(4):547-559.
Hirouchi H, Kitamura K, Yamamoto M, Odaka K, Matsunaga S, Sakiyama K, Abe S. 2018. Developmental characteristics of secondary cartilage in the mandibular condyle and sphenoid bone in mice. Arch Oral Biol. 89:84-92.
Koskinen J, Karlsson J, Olsson PE. 2009. Sox9a regulation of ff1a in zebrafish (danio rerio) suggests an involvement of ff1a in cartilage development. Comp Biochem Physiol A Mol Integr Physiol. 153(1):39-43.
Kuratani S. 2005. Craniofacial development and the evolution of the vertebrates: The old problems on a new background. Zoolog Sci. 22(1):1-19.
Larigot L, Juricek L, Dairou J, Coumoul X. 2018. Ahr signaling pathways and regulatory functions. Biochim Open. 7:1-9.
Larsson M, Fraccalvieri D, Andersson CD, Bonati L, Linusson A, Andersson PL. 2018. Identification of potential aryl hydrocarbon receptor ligands by virtual screening of industrial chemicals. Environ Sci Pollut Res Int. 25(3):2436-2449.
Lee YH, Saint-Jeannet JP. 2011. Sox9 function in craniofacial development and disease. Genesis. 49(4):200-208.
Lefebvre V, Dvir-Ginzberg M. 2017. Sox9 and the many facets of its regulation in the chondrocyte lineage. Connect Tissue Res. 58(1):2-14.
Li M, Wang X, Zhu J, Zhu S, Hu X, Zhu C, Guo X, Yu Z, Han S. 2014. Toxic effects of polychlorinated biphenyls on cardiac development in zebrafish. Mol Biol Rep. 41(12):7973-7983.
Lin Q, He Y, Gui J-F, Mei J. 2021. Sox9a, not sox9b is required for normal cartilage development in zebrafish. Aquaculture and Fisheries. 6(3):254-259.
Lo R, Matthews J. 2012. High-resolution genome-wide mapping of ahr and arnt binding sites by chip-seq. Toxicol Sci. 130(2):349-361.
Nie X. 2006. Sox9 mrna expression in the developing palate and craniofacial muscles and skeletons. Acta Odontol Scand. 64(2):97-103.
Noble C, Jones HA, Damsgard B, Flood MJ, Midling KO, Roque A, Saether BS, Cottee SY. 2012. Injuries and deformities in fish: Their potential impacts upon aquacultural production and welfare. Fish Physiol Biochem. 38(1):61-83.
Olsvik PA, Sorhus E, Meier S, Torvanger I, Thorbjornsen M, Thorsen A, Sorensen L, Fjelldal PG, Karlsen O, Guimaraes IG et al. 2021. Ontogeny-specific skeletal deformities in atlantic haddock caused by larval oil exposure. Front Mar Sci. 8.
Panda M, Tripathi SK, Biswal BK. 2021. Sox9: An emerging driving factor from cancer progression to drug resistance. Biochim Biophys Acta Rev Cancer. 1875(2):188517.
Prasch AL, Heideman W, Peterson RE. 2004. Arnt2 is not required for tcdd developmental toxicity in zebrafish. Toxicol Sci. 82(1):250-258.
Rabie AB, Hägg U. 2002. Factors regulating mandibular condylar growth. Am J Orthod Dentofacial Orthop. 122(4):401-409.
Safe S, Lee SO, Jin UH. 2013. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target. Toxicol Sci. 135(1):1-16.
Shibata S, Suda N, Suzuki S, Fukuoka H, Yamashita Y. 2006. An in situ hybridization study of runx2, osterix, and sox9 at the onset of condylar cartilage formation in fetal mouse mandible. J Anat. 208(2):169-177.
Statello L, Guo CJ, Chen LL, Huarte M. 2021. Gene regulation by long non-coding rnas and its biological functions. Nat Rev Mol Cell Biol. 22(2):96-118.
Stevens EA, Mezrich JD, Bradfield CA. 2009. The aryl hydrocarbon receptor: A perspective on potential roles in the immune system. Immunology. 127(3):299-311.
Van den Berg M, Birnbaum L, Bosveld ATC, Brunstrom B, Cook P, Feeley M, Giesy JP, Hanberg A, Hasegawa R, Kennedy SW et al. 1998. Toxic equivalency factors (tefs) for pcbs, pcdds, pcdfs for humans and wildlife. Environ Health Persp. 106(12):775-792.
Wang Y, Liu C, Rohr J, Liu H, He F, Yu J, Sun C, Li L, Gu S, Chen Y. 2011. Tissue interaction is required for glenoid fossa development during temporomandibular joint formation. Dev Dyn. 240(11):2466-2473.
Watanabe M, Kawasaki K, Kawasaki M, Portaveetus T, Oommen S, Blackburn J, Nagai T, Kitamura A, Nishikawa A, Kodama Y et al. 2016. Spatio-temporal expression of sox genes in murine palatogenesis. Gene Expr Patterns. 21(2):111-118.
Wright EJ, De Castro KP, Joshi AD, Elferink CJ. 2017. Canonical and non-canonical aryl hydrocarbon receptor signaling pathways. Curr Opin Toxicol. 2:87-92.
Xiong KM, Peterson RE, Heideman W. 2008. Aryl hydrocarbon receptor-mediated down-regulation of sox9b causes jaw malformation in zebrafish embryos. Mol Pharmacol. 74(6):1544-1553.
Zhang H, Zhao X, Zhang Z, Chen W, Zhang X. 2013. An immunohistochemistry study of sox9, runx2, and osterix expression in the mandibular cartilages of newborn mouse. Biomed Res Int. 2013:265380.
Zhang N. 2011. The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology. J Cardiovasc Dis Res. 2(2):91-95.